Research ArticleBasic Science Investigation
Improved Modeling of In Vivo Kinetics of Slowly Diffusing Radiotracers for Tumor Imaging
Moses Q. Wilks, Scott M. Knowles, Anna M. Wu and Sung-Cheng Huang
Journal of Nuclear Medicine July 2014, jnumed.114.140038; DOI: https://doi.org/10.2967/jnumed.114.140038
Moses Q. Wilks
1Department of Biomathematics, David Geffen School of Medicine at the University of California–Los Angeles, Los Angeles, California; and
2Department of Molecular and Medical Pharmacology, David Geffen School of Medicine the University of California–Los Angeles, Los Angeles, California
Scott M. Knowles
2Department of Molecular and Medical Pharmacology, David Geffen School of Medicine the University of California–Los Angeles, Los Angeles, California
Anna M. Wu
2Department of Molecular and Medical Pharmacology, David Geffen School of Medicine the University of California–Los Angeles, Los Angeles, California
Sung-Cheng Huang
1Department of Biomathematics, David Geffen School of Medicine at the University of California–Los Angeles, Los Angeles, California; and
2Department of Molecular and Medical Pharmacology, David Geffen School of Medicine the University of California–Los Angeles, Los Angeles, California
Article Figures & Data
Additional Files
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
Improved Modeling of In Vivo Kinetics of Slowly Diffusing Radiotracers for Tumor Imaging
Moses Q. Wilks, Scott M. Knowles, Anna M. Wu, Sung-Cheng Huang
Journal of Nuclear Medicine Jul 2014, jnumed.114.140038; DOI: 10.2967/jnumed.114.140038
Jump to section
Related Articles
Cited By...
- Dual-Isotope Cryoimaging Quantitative Autoradiography: Investigating Antibody-Drug Conjugate Distribution and Payload Delivery Through Imaging
- Practical Immuno-PET Radiotracer Design Considerations for Human Immune Checkpoint Imaging
- Cerenkov Luminescence Imaging as a Modality to Evaluate Antibody-Based PET Radiotracers
- Applications of ImmunoPET: Using 124I-Anti-PSCA A11 Minibody for Imaging Disease Progression and Response to Therapy in Mouse Xenograft Models of Prostate Cancer